122 Labs
122 Labs - we are a technology company created in honour of Jeanne Calment, who died in 1997, at the age of 122 years. Our team’s mission is to change the world so that living until the age of 122 will not be something unusual, and the entire ageing process will be based on Cognition, Mobility and Vitality. We are convinced that the tools which we provide to doctors will significantly increase the average life expectancy in the world and will completely change the lives of millions of elderly people. We believe that thanks to our efforts, the prevention of geriatric diseases, their diagnosis and treatment will reach an unprecedented level. Jeanne Calment - The longest living person whose age was officially confirmed was Jeanne Calment (1875-1997) from France, who survived 122 years and 164 days. When she was one year old, Alexander Graham Bell patented the phone, and when she was 14 years old, the Eiffel Tower was built. Since her childhood, up to the age of 115, she always played sports, and later still maintained regular physical activity. She swam, played tennis, roller-skated, at the age of 80 she began to train fencing, and after reaching 100 years she cycled...
Company Overview
122 Labs is a biotechnology company founded in 2015, headquartered in Palo Alto, California. The company operates as a very small business with a team size of one. It focuses on developing tools aimed at significantly increasing life expectancy, particularly through the prevention, diagnosis, and treatment of geriatric diseases. Inspired by Jeanne Calment, the longest-living person with a verified age, 122 Labs emphasizes the importance of health and longevity.
Products and Services
122 Labs offers a range of products and services designed to enhance health monitoring and rehabilitation. The Blood Pressure Monitor Life Ecosystem X1 and Thermometer Life Ecosystem X1 feature wireless communication via Bluetooth and Wi-Fi, respectively. The Life Ecosystem™ application connects with various health monitoring devices, including ECG Monitors and Glucometers. Additionally, the company provides training plans for seniors to encourage regular exercise. The Rehabilitation Circle™, a multifunctional medical device for comprehensive rehabilitation, is recognized for its innovative design and includes a 21-year warranty.
Technological Innovations
The company utilizes artificial intelligence in its offerings, particularly through the 122 Ecosystem™, which catalogs and analyzes study results to identify dependencies affecting life expectancy. The Life Ecosystem™ application employs an interactive machine learning platform to detect anomalies and potential diseases. This technological approach is central to 122 Labs' mission to revolutionize geriatric healthcare.
Expansion Plans
122 Labs has ambitious plans for expansion, aiming to open 45 clinics in 30 countries by 2025 as part of the 122 Labs Clinics™ initiative. The first two locations were launched in September 2023 in Berlin, Germany, and Warsaw, Poland. Future clinic openings are planned for London, UK, and Miami, USA, in 2024. The company also offers a free franchise concept for rehabilitation specialists, allowing them to operate without initial or ongoing fees.
Industry Focus
Operating within the biotechnology sector, 122 Labs specializes in medicine, rehabilitation, and artificial intelligence. The company's focus on geriatric diseases aligns with its goal of improving health outcomes for older adults. By integrating advanced technology with healthcare solutions, 122 Labs aims to address the challenges associated with aging and enhance the quality of life for seniors.